Sector
PharmaceuticalsOpen
₹904.5Prev. Close
₹906.35Turnover(Lac.)
₹561.28Day's High
₹928Day's Low
₹895.2552 Week's High
₹92952 Week's Low
₹311.6Book Value
₹221.92Face Value
₹5Mkt Cap (₹ Cr.)
1,883.54P/E
31.73EPS
28.5Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 10.4 | 10.46 | 10.9 | 6.41 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 439.89 | 392.2 | 384.23 | 192.58 |
Net Worth | 450.29 | 402.66 | 395.13 | 198.99 |
Minority Interest |
No Record Found
No Record Found
No Record Found
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|---|
Gross Sales | 630.96 | 513.08 | 465.93 | 427.6 | 328.85 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 630.96 | 513.08 | 465.93 | 427.6 | 328.85 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 13.47 | 9.97 | 6.71 | 8.74 | 2.49 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,824.55 | 157.3 | 4,37,806.65 | 237.82 | 0.74 | 4,409.74 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 5,137.8 | 81.93 | 1,36,080.52 | 430 | 0.58 | 2,063 | 507.93 |
Cipla Ltd CIPLA | 1,611.05 | 33.1 | 1,31,478.83 | 1,055.94 | 0.8 | 3,752.25 | 346.4 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,416.7 | 77.52 | 1,16,513.07 | 469 | 0.81 | 2,394 | 201.77 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,100 | 25.69 | 1,12,205.15 | 1,700.8 | 0.27 | 4,035.4 | 156.19 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Independent Directo
Vivek Dhariwal
Whole-time Director
Ashok Kumar Windlass
Managing Director
Hitesh Windlass
Joint Managing Director
Manoj Kumar Windlass
Executive Director
Pawan Kumar Sharma
Non-Exec & Non-Independent Dir
Prachi Jain Windlass
Non-Exec. & Independent Dir.
Srinivasan Venkataraman
Non-Exec. & Independent Dir.
Gaurav Gulati
Company Sec. & Compli. Officer
Ananta Narayan Panda
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Windlas Biotech Ltd
Summary
Windlas Biotech Ltd (formerly known as Windlas Biotech Private Limited) was incorporated in the year 2001. The Company provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world.The company has state-of-the-art manufacturing plant facilities located in Dehradun, Uttarakhand, India. It also has a sales force and distribution network spread across 14 states. The company market its own manufactured authentic nutraceutical, pharmaceutical and Ayurvedic products to serve the semi-urban and rural communities at affordable prices. Apart from this, the company has three distinct strategic business verticals (SBVs) mainly comprising of CDMO services and products; domestic trade generics and over-the-counter (OTC) brands; and exports.The company provides a comprehensive range of CDMO services ranging from product discovery, product development, licensing and commercial manufacturing of generic products, including complex generics, in compliance with current Good Manufacturing Practices (GMP) with a focus on improved safety, efficacy and cost. In addition to this, it sells its own branded products in the trade generics and OTC markets as well as export generic products to several countries. Moreover, the company has significant experience in developing and manufacturing generic fixed dose combinations. Its focus has currently been in launching new complex generic products in
Read More
The Windlas Biotech Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹901.2 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Windlas Biotech Ltd is ₹1883.54 Cr. as of 06 Sep ‘24
The PE and PB ratios of Windlas Biotech Ltd is 31.73 and 4.20 as of 06 Sep ‘24
The 52-week high/low is the highest and lowest price at which a Windlas Biotech Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Windlas Biotech Ltd is ₹311.6 and ₹929 as of 06 Sep ‘24
Windlas Biotech Ltd's CAGR for 5 Years at 17.36%, 3 Years at 32.03%, 1 Year at 133.75%, 6 Month at 65.71%, 3 Month at 42.28% and 1 Month at 14.95%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice